Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 7,195.7 | 10,311.3 | 11,545.4 | 11,115.8 | 11,957.9 | 11,276.4 | 2,430.6 | 17,062.7 |
| Revenue growth | -30.2% | -10.7% | 3.9% | -7.0% | 6.0% | 363.9% | -85.8% | -6.5% |
| Cost of goods sold | 3,173.9 | 4,502.2 | 5,039.9 | 4,710.0 | 4,963.3 | 4,633.1 | 1,060.0 | 6,273.4 |
| Gross profit | 4,021.8 | 5,809.1 | 6,505.5 | 6,405.8 | 6,994.6 | 6,643.3 | 1,370.6 | 10,789.3 |
| Gross margin | 55.9% | 56.3% | 56.3% | 57.6% | 58.5% | 58.9% | 56.4% | 63.2% |
| Selling, general and administrative | 1,618.5 | 2,154.1 | 2,150.0 | 2,044.2 | 2,049.1 | 1,980.4 | 170.8 | 2,928.8 |
| EBITA | -592.2 | 1,596.4 | 2,057.2 | 1,141.5 | 1,719.7 | 1,380.3 | 139.8 | 3,508.7 |
| EBITA margin | -8.2% | 15.5% | 17.8% | 10.3% | 14.4% | 12.2% | 5.8% | 20.6% |
| Amortization of intangibles | 443.7 | 470.5 | 174.2 | 524.7 | 641.1 | 603.2 | | 1,311.9 |
| EBIT | -1,035.9 | 1,125.9 | 1,883.0 | 616.8 | 1,078.6 | 777.1 | 139.8 | 2,196.8 |
| EBIT margin | -14.4% | 10.9% | 16.3% | 5.5% | 9.0% | 6.9% | 5.8% | 12.9% |
| Pre-tax income | 1,424.2 | 14,000.8 | -1,801.0 | -1,241.9 | 161.8 | -2,111.1 | -627.6 | -776.9 |
| Income taxes | 318.9 | 473.3 | -275.9 | 234.0 | 1,573.3 | 238.9 | -183.0 | 324.3 |
| Tax rate | 22.4% | 3.4% | 15.3% | | 972.4% | | 29.2% | |
| Earnings from continuing ops | 592.2 | 13,344.2 | -3,211.5 | -1,592.7 | -2,947.7 | -2,407.5 | -444.6 | -2,305.4 |
| Earnings from discontinued ops | 881.0 | 82.6 | 58.4 | 13,114.1 | 2,261.5 | -370.6 | | 51.7 |
| Net income | 1,473.2 | 13,426.8 | -3,153.1 | 11,521.4 | -686.2 | -2,778.1 | -444.6 | -2,253.7 |
| Net margin | 20.5% | 130.2% | -27.3% | 103.6% | -5.7% | -24.6% | -18.3% | -13.2% |
| |
| Diluted EPS | $1.19 | $23.45 | ($5.33) | ($2.26) | ($3.79) | ($2.84) | | |
| Shares outstanding (diluted) | 497.0 | 569.1 | 602.1 | 705.8 | 778.7 | 847.9 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|